Go to Page # Page of 32
loading

Molecular Templates: Corporate Presentation March 2019

 Molecular Templates Inc.
  29th-Apr-2019
Description: Molecular Templates is developing novel oncology therapies with engineered toxin bodies (ETBs). ETBs use an antibody domain for targeting fused to a de-immunized Shiga-like toxin A subunit (SLTA).
Views: 2735
Domain: Medical
Category: Biology
Contributing Organization: Molecular Templates Inc.
 ‐ More of their Presentations
Contents:
1

MOLECULAR TEMPLATES
Corporate Presentation I March 2019

(NASDAQ: MTEM)

Forward-Looking Statements
Except for statements of historical fact, the statements in this presentation are forward-looking statements, including statements regarding the
future development of our proprietary Engineered Toxin Body (ETB) technology; the future development of evofosfamide; our milestones; our
plans to ente ... See more

Recent Presentations

ASPR Tracie Resources Overview 2019

The healthcare supply chain is confronted with many small to large daily challenges & under distinct strains during disasters. while HCC supply chain integrity self-assessment.

...
22 September, 2019
...
21 September, 2019
Yoojin Oh
20 September, 2019